12.01.2016
- Globally, mergers and acquisitions at a value of USD 372 billion were recorded in the chemical and pharmaceutical sector in 2015. This amounts to an increase of 74% compared with...
11.01.2016
- Sanofi has handed back rights to the inhaled insulin treatment Afrezza to US drug development company MannKind. Sales of Afrezza, which launched in the US in February last year...
23.12.2015
- Bayer is likely to seek a major life sciences M&A deal in the next few years, banking sources have told the news agency Reuters. The German group’s absence from a recent wave of...
16.12.2015
- French drugmaker Sanofi and German pharmaceutical company Boehringer Ingelheim have begun exclusive negotiations toward a swap of Sanofi’s subsidiary Merial, a manufacturer of...
15.12.2015
- Mexico has granted marketing authorization to Sanofi Pasteur for its dengue vaccine, Dengvaxia. The vaccine is the world’s first to be approved for preventing the disease which is...
30.11.2015
- Drugs firms AstraZeneca and Sanofi are to exchange 210,000 compounds from their libraries to help boost their search for new small-molecule medicines. The companies have selected...
13.11.2015
- French drugmaker Sanofi has entered into two separate collaborations to develop and commercialize diabetes treatments. An agreement with US-based Lexicon Pharmaceuticals centers on...
12.11.2015
- French drugmaker Sanofi has announced a new long-term strategy focused on four pillars including a reshaping of its portfolio, new drug launches, innovation in R&D and a...
